Zyagen

Zyagen is a privately held, revenue-generating biotechnology company that operates as a specialized supplier and service provider in the research tools sector. The company develops, manufactures, and sells a portfolio of molecular biology products including RNA, genomic DNA, tissue lysates, cDNA, antibodies, and assay kits, while also offering custom histology and molecular biology research services. Its business model is centered on supporting basic and translational research, with a stated goal of simplifying and accelerating scientific discovery. While not a therapeutic developer, Zyagen occupies a stable niche as an enabler of genomics and proteomics research.

Expertise in molecular biology and histology services for gene expression analysis, including nucleic acid isolation, protein analysis, tissue sectioning, and antibody development.

Zyagen competes in the fragmented life science research tools market, against giants like Thermo Fisher Scientific and Merck KGaA, as well as many specialized reagent and service providers. Its differentiation relies on niche product quality (e.g., specific tissue RNAs), a broad species range, and integrated custom service capabilities, rather than competing on price or scale alone.